Review of prognostic factors for kidney transplant survival


Zulkhash N. Shanazarov N. Kissikova S. Kamelova G. Ospanova G.
November 2023SAGE Publications Ltd

Urologia Journal
2023#90Issue 4611 - 621 pp.

Transplantation is the most effective treatment for end-stage chronic kidney disease, as this procedure prolongs and improves the patient’s quality of life. One of the key problems is the risk of graft rejection. The purpose of this research was to identify and analyse prognostic factors that will prevent rejection. In particular, the prognostic factors grouped by methods of synthesis, generalisation and statistical processing with calculation and graphical representation of hazard ratio and correlation coefficient were grouped, namely: age of donor and recipient, time of cold kidney ischaemia, duration of preoperative dialysis, body mass index, presence of concomitant diseases (diabetes mellitus, hypertension), primary causes causing transplantation. Several molecular genetic and biochemical prognostic markers (transcription factors, immunocompetent cell signalling and receptors, cytostatin C, creatinine, citrate, lactate, etc.) are annotated. It has been demonstrated that creatinine reduction rate determines the risk of rejection, displaying the dynamics of cystatin C and creatinine changes in the postoperative period. Young recipients who underwent prolonged preoperative dialysis were identified as having the highest risk of rejection. Diabetes and hypertension bear a non-critical but commensurately equal risk of rejection. The survival rate of the graft is better when transplanted from a living donor than from a deceased donor. A correlation between cold ischaemia time, body mass index and the probability of graft failure has been proven, namely, the greater the donor and recipient body mass index and the longer the cold ischaemia time, the lower the chance of successful long-term organ acclimation. The data obtained can be used as prognostic factors for graft accommodation at different intervals after surgery.

antigen incompatibility , cold ischaemia , Creatinine , diabetes mellitus , dialysis , rejection

Text of the article Перейти на текст статьи

Department of Public Health, Astana Medical University, Astana, Kazakhstan
Department of Strategic Development, Science and Education, Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan
Medical Center of the President’s Affairs Administration of the Republic of Kazakhstan, Astana, Kazakhstan
Department of Otorhinolaryngology and Ophthalmology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

Department of Public Health
Department of Strategic Development
Medical Center of the President’s Affairs Administration of the Republic of Kazakhstan
Department of Otorhinolaryngology and Ophthalmology

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026